Details for Patent: 9,694,025

« Back to Dashboard

Which drugs does patent 9,694,025 protect, and when does it expire?

Patent 9,694,025 protects VABOMERE and is included in one NDA.

This patent has fifty-five patent family members in twenty-seven countries.

Summary for Patent: 9,694,025

Title:	Cyclic boronic acid ester derivatives and therapeutic uses thereof
Abstract:	Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to cyclic boronic acid ester derivatives and their use as therapeutic agents.
Inventor(s):	Gavin Hirst, Raja Reddy, Scott Hecker, Maxim Totrov, David C. Griffith, Olga Rodny, Michael N. Dudley, Serge Boyer
Assignee:	Melinta Subsidiary Corp
Application Number:	US15/015,002
Patent Claim Types: see list of patent claims	Use; Delivery;

Drugs Protected by US Patent 9,694,025

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Rempex	VABOMERE	meropenem; vaborbactam	POWDER;INTRAVENOUS	209776-001	Aug 29, 2017		RX	Yes	Yes	9,694,025					TREATMENT OF PATIENTS 18 YEARS OF AGE AND OLDER WITH COMPLICATED URINARY TRACT INFECTIONS CAUSED BY SUSCEPTIBLE MICROORGANISMS

International Family Members for US Patent 9,694,025

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2603514		300977	Netherlands
European Patent Office	2603514		300978	Netherlands
European Patent Office	2603514		122019000027	Germany
European Patent Office	2603514		CA 2019 00015	Denmark